Childhood B Acute Lymphoblastic Leukemia

Childhood B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

36 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02227108	Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma	terminated	Phase 2	37	MedImmune LLCINDUSTRY	8	Apr 6, 2017	clinicaltrials
NCT00101205	Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma	terminated	Phase 1	40	National Cancer Institute (NCI)NIH	1	Feb 24, 2014	clinicaltrials